TRCT
ICCM icon

Tower Research Capital (TRC)’s IceCure Medical ICCM Stock Holding History

Tower Research Capital (TRC)’s Portfolio ICCM Stock Details ICCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10
Closed -$323 – 5470
2024
Q4 		$323 Hold
10
– – ﹤0.01% 5327
2024
Q3 		$179 Hold
10
– – ﹤0.01% 5442
2024
Q2 		$218 Hold
10
– – ﹤0.01% 5402
2024
Q1 		$353 Hold
10
– – ﹤0.01% 5532
2023
Q4 		$315 Hold
10
– – ﹤0.01% 5612
2023
Q3 		$159 Buy
10
+7
+233% +$220 ﹤0.01% 5682
2023
Q2 		$104 Buy
+3
New +$107 ﹤0.01% 5815
2023
Q1 		– Hold
0
– – – 6035
2022
Q4 		– Hold
0
– – – 6117
2022
Q3 		– Hold
0
– – – 6253
2022
Q2 		– Hold
0
– – – 6262
2022
Q1 		– Hold
0
– – – 6288
2021
Q4 		– Sell
-3
Closed -$1K – 6326
2021
Q3 		$1K Buy
+3
New +$889 ﹤0.01% 5486

Other funds holding ICCM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tower Research Capital (TRC)'s ICCM Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of IceCure Medical (ICCM) in Q1 2025, closing a stake of 10 shares — an estimated $323 sold.

Tower Research Capital (TRC) first reported a position in ICCM in Q3 2021 and held it in 8 quarters. The position peaked at $1K in Q3 2021. 13 funds tracked by Wall St. Rank hold ICCM as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining IceCure Medical position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 10 IceCure Medical shares in Q1 2025, an estimated $323.
  • Tower Research Capital (TRC) first reported a position in IceCure Medical in Q3 2021 and held it in 8 quarters.
  • Tower Research Capital (TRC)'s IceCure Medical position peaked at $1K in Q3 2021.
  • 13 funds tracked by Wall St. Rank held IceCure Medical as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.